The Bird & Be Co.

The Bird & Be Co. is a technology company.

Active

Updated: Mar 21, 2026 ·

About

The Bird & Be Co. provides specialized fertility-supporting products and services, including doctor-formulated prenatal vitamins, targeted supplements, and at-home tests. These clinically-backed offerings cater to both females and males through their conception journey. The company prioritizes product integrity, manufacturing supplements in GMP-certified facilities and securing necessary health licenses.

The company was established from an understanding that comprehensive fertility support should be accessible and less overwhelming. It arose from the insight that reliable, convenient resources are needed at home, addressing the complexities of pursuing pregnancy. This principle guides Bird & Be's commitment to empowering users with informed decisions.

Bird & Be serves individuals and couples actively engaged in or preparing for their fertility path, offering trusted tools for reproductive health. Its vision aims to demystify the fertility process, cultivating a supportive ecosystem through its science-backed offerings. The company endeavors to be a vital partner, continually enhancing accessible care solutions.

Recent News & Mentions

Sep 1, 2021FundingThe Bird & Be Co. - Seed

Financial History

The Bird & Be Co. has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in September 2021.

Total Raised

$2.0M

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Sep 1, 2021	$2.0M Seed		Accomplice VC, Alumni Ventures, Cubit Capital, Aniq Kassam, Founder Collective, Matrix, Night Capital, SignalFire, Susa Ventures, Trust Ventures, Urban Innovation Fund, Sunil Paul, Travis May

Financial History

The Bird & Be Co. has raised $2.0M across 1 funding round.

Total Raised

$2.0M

Valuation

N/A

Deep Dive

The Bird & Be Co. is a Toronto-based consumer health technology company that builds DTC fertility and reproductive-health products and at‑home diagnostic tools aimed at making fertility care more accessible, personalized, and convenient for people trying to conceive and through pregnancy and postpartum. [1][6]

High-Level Overview

Bird & Be is a direct-to-consumer fertility and reproductive‑health company that offers personalized supplement packs, education, and at‑home tests and tools intended to optimize fertility outcomes and accelerate time to care for people with eggs and sperm [1][6].- The company’s product mix combines *education* (doctor‑reviewed content and early screening diagnostics) and *action* (customized supplements, prescriptions/referrals, and planned at‑home tests such as ovulation, pregnancy, sperm tests and a patent‑pending ovarian‑reserve urine stick) to lower barriers of access related to information, cost and geography[1][4][6].- Bird & Be serves aspiring parents and pregnant/postpartum people who want a more modern, convenient, and inclusive path to fertility care; it positions itself at the intersection of consumer wellness, telehealth-enabled care pathways, and at‑home diagnostics [1][3][6].

Origin Story

Founders and background: Bird & Be was founded by Samantha Diamond (CEO) and Breanna Hughes (COO), who launched the business after their own fertility journeys revealed gaps in accessible, practical fertility care; they built a team that includes reproductive endocrinologists and naturopathic doctors to combine conventional and naturopathic approaches[4][6].- How the idea emerged: The founders developed the company to provide the products and resources they wished they’d had—convenient, evidence‑backed supplements, clear education, and affordable at‑home testing—packaged for everyday use and backed by clinical expertise[4][6].- Early traction / pivotal moments: Bird & Be launched with a signature line of supplements (including daily single‑serve sachets and subscription options) and announced seed funding and product expansion plans—including at‑home tests and a patent‑pending ovarian reserve urine test—marking early validation of market demand for DTC fertility solutions[1][4].

Core Differentiators

Product + clinical blend: Combines reproductive endocrinology and naturopathic expertise to design formulas and care pathways, positioning products as both *clinically informed* and *holistic*[6].- Personalization and convenience: Tailors supplement packs via an intake quiz and delivers daily single‑serve sachets and subscription fulfillment to remove complexity from nutrient regimens[4][6].- At‑home diagnostics roadmap: Moves beyond supplements into at‑home testing (ovulation, pregnancy, sperm, and an ovarian reserve urine stick) to provide earlier, actionable fertility insights without clinic visits[1].- Inclusive positioning and education: Emphasizes accessible, stigma‑free care for diverse family‑building paths, paired with doctor‑reviewed content and referral networks to higher‑touch care when needed[6].

Role in the Broader Tech Landscape

Trend alignment: Bird & Be rides the consumerization of healthcare—specifically DTC health and fertility tech—where convenience, at‑home diagnostics, and subscription wellness services converge to decentralize early screening and care[1][3].- Why timing matters: Rising demand for fertility services, greater acceptance of telehealth and at‑home testing, and consumer appetite for personalized wellness create a fertile environment for companies that can combine credible clinical input with consumer UX and logistics[1][6].- Market forces in their favor: Consumers seeking earlier insight into fertility, affordability pressures in traditional fertility care, and digital distribution channels (subscriptions, social media education) help scale DTC models that reduce friction to first‑line action and triage to clinical care[1][4].- Ecosystem influence: By offering low‑barrier screening and education, Bird & Be can increase early detection and appropriate referrals, potentially shifting the funnel of patients who enter specialty fertility clinics and accelerating the market for adjunctive telehealth and diagnostics[1][6].

Quick Take & Future Outlook

Near term: Expect continued product expansion (commercial roll‑out of planned at‑home tests, refinement of personalized supplement offerings, and growth of subscription revenues) and greater emphasis on clinical validation and partnerships to drive trust and conversion[1][4].- Medium term: If Bird & Be successfully brings patent‑pending diagnostics to market and demonstrates clinical sensitivity/specificity, it could deepen referral relationships with clinics and payers and become a standard front‑end for fertility triage and early intervention[1].- Risks & signals to watch: Regulatory and accuracy hurdles for at‑home diagnostics, competition from larger DTC health brands and specialized fertility platforms, and the need to demonstrate measurable clinical outcomes vs. wellness positioning are key factors that will shape trajectory.- Final thought: Bird & Be’s combination of clinician‑backed product design, consumer convenience (single‑serve subscriptions), and a roadmap into at‑home diagnostics positions it as a notable player in the consumer fertility tech wave—one that could meaningfully change how people access early fertility insights and basic interventions if it proves product and clinical efficacy at scale[1][6][4].

Sources cited above are Bird & Be’s company materials and published reporting on their seed launch and product roadmap[1][4][6].

Sources

Frequently Asked Questions

How much funding has The Bird & Be Co. raised?

The Bird & Be Co. has raised $2.0M in total across 1 funding round.

Who are The Bird & Be Co.'s investors?

The Bird & Be Co.'s investors include Accomplice VC, Alumni Ventures, Cubit Capital, Aniq Kassam, Founder Collective, Matrix, Night Capital, SignalFire, Susa Ventures, Trust Ventures, Urban Innovation Fund, Sunil Paul.